These two trials are sponsored by Mesoblast, so Dr Amy’s role here is in fact the Mesoblast consultant.
She is also involved with another company that is interested in using extracellular vesicles (EVs) coming from MPCs for the treatment of IBDs. Someone other poster previously assured me that our patents also covers EVs. In addition IBD indication goes back to the Osiris time and I am quite sure our patents are very strong to protect our IPs for this indication.
banter and General Discussion, page-9333
-
- There are more pages in this discussion • 494 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.16 |
Change
0.015(1.32%) |
Mkt cap ! $1.301B | |||
| Open | High | Low | Value | Volume |
| $1.14 | $1.17 | $1.14 | $2.260M | 1.961M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 67026 | $1.16 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.16 | 51905 | 13 |
View Market Depth
| Last trade - 10.41am 19/06/2024 (20 minute delay) ? |
| MSB (ASX) Chart |